Información del artículo
El Texto completo está disponible en PDF
Biblografía
[1.]
R.R. Crowe.
Electroconvulsive therapy: a current perspective.
N Engl J Med, 311 (1984), pp. 163-167
[2.]
K.G. Kelly, M. Zisselman.
Update on electroconvulsive therapy (ECT) in older adults.
J Am Geriatr Soc, 48 (2000), pp. 560-566
[3.]
M. Bernardo, V. Navarro, J. Salva, F.J. Arrufat, I. Baeza.
Seizure activity and safety in combined treatment with venlafaxine and ECT: a pilot study.
J ECT, 16 (2000), pp. 38-42
[4.]
R.M. Jones, P.R. Knight.
Cardiovascular and hormonal responses to electroconvulsive therapy.
Anaesthesia, 36 (1981), pp. 795-799
[5.]
P.O. Bodley, P.B. Fenwick.
The effects of electroconvulsive therapy on patients with essential hypertension.
Br J Psychiatry, 112 (1966), pp. 1241-1249
[6.]
R. Luque, J.M. Valls.
Síndrome de Cotard: aspectos históricos y conceptuales.
Actas Luso Esp Neurol Psiquiatr Cienc Afines, 4 (1994), pp. 178-188
[7.]
A.J. Rampton, R.M. Griffin, C.S. Stuart, J.J. Durcan, N.C. Huddy, M.A. Abbot.
Comparasion of methoexital and propofol for electroconvulsive therapy: effects on hemodynamic responses and seizure duration.
Anesthesiology, 70 (1989), pp. 412-417
[8.]
A. Villalonga, T. Planella, J. Castillo, C. Hernández, C. Cabrer, M. Manalich, et al.
Nitroglicerina en nebulizador en la profilaxis de la hipertensión inducida por la terapia electrocunvulsiva.
Rev Esp Anestesiol Reanim, 36 (1989), pp. 264-266
[9.]
J.R. Nurenberg.
Intravenous nitroglycerine in the management of posttreatment hypertension during electroconvulsive therapy.
J Nerv Ment Dis, 179 (1991), pp. 291-294
Copyright © 2002. Sociedad Española de Geriatría y Gerontología
